Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Nicole Liffrig Molife

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
healthcare, healthcare and FDA regulatory, healthcare and regulatory
Office
Washington, D.C.
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPOM&APrivate Equity & BuyoutsVenture Capital & Growth
Sectors
Healthcare & Life Sciences
Jurisdictions
FloridaNew YorkUnited States

Recent deals

18 announced deals in the record
Latham Advises Mineralys Therapeutics in Unique Three-Pronged Transaction — Royalty Repurchase, Debt Financing, and Equity Offering — Totaling Up to US$950 Million 8 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 950m healthcare matters
Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase 6 Mar 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 41.1 healthcare
Latham & Watkins Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase 22 Oct 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP healthcare
Latham & Watkins Advises Nalu Medical, Inc. on Acquisition by Boston Scientific 21 Oct 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 533m healthcare regulatory Washington, D.C.
Latham Advises on Private Debt Financing for HSS and General Atlantic’s Acquisition of Legent Health 20 Oct 2025
Private Equity & Buyouts Healthcare & Life Sciences Latham & Watkins LLP healthcare
Latham & Watkins Advises on Concentra IPO 26 Jul 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 23.5 healthcare regulatory matters
Latham Advises on Financing for Frazier Healthcare Partners’ Completed Acquisition of BioMatrix 3 Jul 2024
Private Equity & Buyouts Healthcare & Life Sciences Latham & Watkins LLP healthcare regulatory Washington, D.C.
Latham & Watkins Advises TPG on Investment in K2 Medical Research 28 Jun 2024
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP healthcare Washington, D.C.
Latham & Watkins Advises Goldman Sachs in Acquisition of Xpress Wellness 24 May 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP healthcare regulatory Washington, D.C.
Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz 22 Jan 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 170m healthcare regulatory Washington, D.C.
Deal alerts PRO

Get an email when Nicole Liffrig Molife is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

See all 18 deals for Nicole Liffrig Molife

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction